Cargando…

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides

Current treatments for autoimmune disorders rely on non-specific immunomodulatory and global immunosuppressive drugs, which show a variable degree of efficiency and are often accompanied by side effects. In contrast, strategies aiming at inducing antigen-specific tolerance promise an exclusive speci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfeil, Jennifer, Simonetti, Mario, Lauer, Uta, Volkmer, Rudolf, von Thülen, Bianca, Durek, Pawel, Krähmer, Ralf, Leenders, Frank, Hamann, Alf, Hoffmann, Ute
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581722/ https://www.ncbi.nlm.nih.gov/pubmed/33162973 http://dx.doi.org/10.3389/fimmu.2020.529035

Ejemplares similares

Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
por: Pfeil, Jennifer, et al.
Publicado: (2021)

Peptides reloaded - new strategies for tolerogenic vaccination
por: Hamann, Alf, et al.
Publicado: (2011)

Facilitated Peptide Transport via the Mucosal Epithelium: Impact on Tolerance Induction
por: Kenngott, Elisabeth E., et al.
Publicado: (2017)

Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation
por: von Websky, Martin W., et al.
Publicado: (2016)

Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Regulation and Migratory Role of P-Selectin Ligands during Intestinal Inflammation
por: Hoffmann, Ute, et al.
Publicado: (2013)

Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia
por: Sands, Earl, et al.
Publicado: (2022)

Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes
por: Hayashi, Tomoko, et al.
Publicado: (2015)

TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer
por: Matthaiou, Efthymia-Iliana, et al.
Publicado: (2022)

Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis
por: Milioti, Natalia, et al.
Publicado: (2008)

Tolerogenic effect of non-inherited maternal antigens in hematopoietic stem cell transplantation
por: Hirayama, Masahiro, et al.
Publicado: (2012)

LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells
por: Anderson, Amy E., et al.
Publicado: (2009)

Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
por: Castenmiller, Charlotte, et al.
Publicado: (2021)

Soluble antigen arrays improve the efficacy and safety of peptide-based tolerogenic immunotherapy
por: Firdessa-Fite, Rebuma, et al.
Publicado: (2023)

Tolerogenic therapies in transplantation
por: Page, Eugenia K., et al.
Publicado: (2012)

Antigen-Specific Tolerogenic Dendritic Cells Ameliorate the Severity of Murine Collagen-Induced Arthritis
por: Ning, Bin, et al.
Publicado: (2015)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

Tolerogenic citrullinated peptide for arthritis
por: Gertel, Smadar, et al.
Publicado: (2015)

Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis
por: Gomi, Masaki, et al.
Publicado: (2023)

Human Cytomegalovirus Drives Epigenetic Imprinting of the IFNG Locus in NKG2C(hi) Natural Killer Cells
por: Luetke-Eversloh, Merlin, et al.
Publicado: (2014)

Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)
por: Kivitz, Alan, et al.
Publicado: (2023)

Tolerogenicity of resting and activated B cells
Publicado: (1994)

Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017)

Tolerogenic vaccines for the treatment of cardiovascular diseases
por: Vigario, Fernando Lozano, et al.
Publicado: (2020)

The Effects of Tamoxifen on Tolerogenic Cells in Cancer
por: Mohd Idris, Ros Akmal, et al.
Publicado: (2022)

Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine
por: Popov, Igor, et al.
Publicado: (2006)

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
por: Meliani, Amine, et al.
Publicado: (2018)

Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase
por: Xu, Yanying, et al.
Publicado: (2017)

PEGylation and folic-acid functionalization of cationic lipoplexes—Improved nucleic acid transfer into cancer cells
por: Hoffmann, Marco, et al.
Publicado: (2022)

Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
por: Nikolic, Tatjana, et al.
Publicado: (2013)

The gene expression profile of preclinical autoimmune arthritis and its modulation by a tolerogenic disease-protective antigenic challenge
por: Yu, Hua, et al.
Publicado: (2011)

Cestode Antigens Induce a Tolerogenic-Like Phenotype and Inhibit LPS Inflammatory Responses in Human Dendritic Cells
por: Terrazas, César A., et al.
Publicado: (2011)

Thymic Self-Antigen Expression for the Design of a Negative/Tolerogenic Self-Vaccine against Type 1 Diabetes
por: Chentoufi, Aziz Alami, et al.
Publicado: (2011)

TRANSFORMATION OF A HISTOCOMPATIBILITY IMMUNOGEN INTO A TOLEROGEN
por: Nimelstein, Stephen H., et al.
Publicado: (1973)

Inducing a tolerogenic microenvironment within tissues
por: Cobbold, Stephen P
Publicado: (2011)

Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2011)

Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2012)

Tolerogenic and Activatory Plasmacytoid Dendritic Cells in Autoimmunity
por: Guéry, Leslie, et al.
Publicado: (2013)

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications
por: Yoo, Seungbo, et al.
Publicado: (2016)

Metabolism Is Central to Tolerogenic Dendritic Cell Function
por: Sim, Wen Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sh6c6bo6t7ukn6ju1n1rgcqrtg